Zura Corp Information

Zura is your one stop shop for pharmaceutical projects - connecting end to end & everything in between in a product’s life cycle, lab to launch. Zura is jointly developing various NCE-1, Para IV & niche segment molecules with key partners in USA & India ready for launch in 2018-19. We are open to new collaborations for in-licensing the dossier development for regulatory/ROW markets. With a product pipeline identified using regulatory strategy, driven by market demand and backed by strong technical team, it’s a definite win! With a flexible and creative approach to collaborations and the ability to respond rapidly to opportunities, Zura’s team of business development and alliance management experts oversee the selection and review of in-licensing and collaboration opportunities, to build strong relationships that are mutually beneficial to all parties. Our activities are focused on generic products that are in late-stage development, currently approved and commercialized outside the US , EU, Canada , or ROW markets approved in the US, EU , Canada or ROW but falling outside the license holder’s business focus. We will consider in-licensing, joint development, co-promotion, revenue-sharing, and other partnering opportunities